Skip to main navigation Skip to search Skip to main content

Supporting smoking cessation

  • Nicholas A. Zwar*
  • , Colin P. Mendelsohn
  • , Robyn L. Richmond
  • *Corresponding author for this work

Research output: Contribution to journalArticleResearchpeer-review

Abstract

Summary points
- Throughout the world tobacco smoking is the leading cause of preventable death and illness
- As smoking rates in the general population fall in developed countries, a greater proportion of smokers have coexisting problems such as mental illness
- Cessation support from doctors and other health professionals increases quit rates
- Tobacco dependence is most effectively treated with a comprehensive approach involving behavioural support and pharmacotherapy
- Effective medicines include nicotine replacement therapy, varenicline, bupropion, nortriptyline, and cytisine. The availability and registration of these medicines varies between countries
Original languageEnglish
Article numberf7535
JournalBMJ (Online)
Volume348
DOIs
Publication statusPublished - 14 Jan 2014
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Supporting smoking cessation'. Together they form a unique fingerprint.

Cite this